
    
      This is a prospective study of subjects who have been diagnosed with bilateral demodex
      blepharitis. Qualified symptomatic eyes will be randomized and monitored for 30 days; one eye
      will undergo Avenova treatment twice daily and one eye will not undergo any study treatment.
    
  